Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation
Figure 2.Survival curves for patients with localized NKTCL receiving sequential chemoradiotherapy. Progression-free survival and overall survival cures for the primary cohort (A and B) and the validation cohort (C and D).